These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35373125)

  • 1. A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.
    Seethapathy R; Zhao S; Long JD; Strohbehn IA; Sise ME
    Kidney360; 2022 Feb; 3(2):269-278. PubMed ID: 35373125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort.
    Ackley TW; McManus D; Topal JE; Cicali B; Shah S
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.
    Seethapathy R; Wang Q; Zhao S; Strohbehn IA; Long JD; Dinulos JE; Harden D; Kadiyala VB; Moreno D; Sise ME
    PLoS One; 2023; 18(2):e0279765. PubMed ID: 36848366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.
    Chang HY; Hsu CC; Hu LF; Chou CY; Chang YL; Lu CC; Chang LJ
    Ann Med; 2024 Dec; 56(1):2361843. PubMed ID: 38830017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment.
    Chang MC; Wu PF; Ho YC; Lin WY; Wu CY; Liu SY; Liu CJ; Lin YT
    J Infect Public Health; 2024 Jul; 17(7):102460. PubMed ID: 38820894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
    Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A
    Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
    Biancalana E; Chiriacò M; Sciarrone P; Mengozzi A; Mechelli S; Taddei S; Solini A
    Clin Interv Aging; 2021; 16():1037-1046. PubMed ID: 34113086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    Gonzalez Suarez ML; Mara KC; Rivera CG; Chesdachai S; Draper E; Razonable RR
    PLoS One; 2024; 19(6):e0303896. PubMed ID: 38875257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency.
    Park S; Kim AR; Lee J; Kang SW; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    J Infect Chemother; 2024 Apr; 30(4):366-370. PubMed ID: 37935348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia.
    Cacho J; Burgos E; Molina M; Villegas A; Pérez M; Cañas L; Taco O; Juega J; Lauzurica R
    Nefrologia (Engl Ed); 2022; 42(3):311-317. PubMed ID: 36210620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids.
    Kuno T; Miyamoto Y; Iwagami M; Ishimaru M; Takahashi M; Egorova NN
    J Antimicrob Chemother; 2021 Sep; 76(10):2690-2696. PubMed ID: 34368850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
    Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
    JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients.
    Player B; Huppler AR; Pan AY; Liegl M; Havens PL; Ray K; Mitchell M; Graff K
    BMC Infect Dis; 2024 Sep; 24(1):987. PubMed ID: 39289614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
    Singh A; Kamath A
    Expert Opin Drug Saf; 2021 Dec; 20(12):1559-1564. PubMed ID: 34328807
    [No Abstract]   [Full Text] [Related]  

  • 18. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
    Patel RH; Pella PM; Haider N; Blanco R
    Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
    Wong CKH; Lau KTK; Au ICH; Xiong X; Lau EHY; Cowling BJ
    Clin Infect Dis; 2022 Apr; 74(8):1450-1458. PubMed ID: 34265054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.